An observational study to evaluate the quality of life of patients treated with phytotherapy or alpha-blockers for benign prostatic hyperplasia (PERQOL).
An observational study to evaluate the quality of life of patients treated with phytotherapy or alpha-blockers for benign prostatic hyperplasia (PERQOL).
A 6-months prospective, observational study to evaluate the quality of life of patients treated with phytotherapy or alpha-blockers for benign prostatic hyperplasia.
Brief summary
Benign prostatic hyperplasia (BPH) is a very common disease of aging men (over half of the population concerned after 50 years). In some cases, BPH induces urinary discomfort and disturbances called lower urinary tract symptoms (LUTS). BPH may also be associated to sexual dysfunction.
BPH can have a marked effect on patient’s quality of life (QoL), particularly when symptoms are moderate or severe.
In this context, the purpose of PERQOL, a prospective and observational study, is to assess the impact of LUTS/BPH treatment on patients’ QoL and sexual function using dedicated questionnaires.
Contact Us
Need more information, click on the button to have access to the contact form.
Access to Lay Protocol Synopsis
Un résumé du protocole rédigé en termes simples et décrivant les objectifs de l’étude vous est proposé